Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 5
2018 1
2019 3
2020 3
2021 2
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients.
Besutti G, Giorgi Rossi P, Ottone M, Spaggiari L, Canovi S, Monelli F, Bonelli E, Fasano T, Sverzellati N, Caruso A, Facciolongo N, Ghidoni G, Simonazzi A, Iori M, Nitrosi A, Fugazzaro S, Costi S, Croci S, Teopompi E, Gallina A, Massari M, Dolci G, Sampaolesi F, Pattacini P, Salvarani C. Besutti G, et al. Among authors: teopompi e. Sci Rep. 2022 Mar 11;12(1):4270. doi: 10.1038/s41598-022-08026-1. Sci Rep. 2022. PMID: 35277562 Free PMC article.
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
Cassone G, Dolci G, Besutti G, Muratore F, Bajocchi G, Mancuso P, Catanoso M, Spaggiari L, Galli E, Palermo A, Pipitone N, Croci S, Massari M, Facciolongo N, Menzella F, Negri EA, Zerbini A, Belloni L, Cimino L, Teopompi E, Sampaolesi F, Salsi P, Costantini M, Giorgi Rossi P, Aldigeri R, Salvarani C. Cassone G, et al. Among authors: teopompi e. Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1215-1222. Epub 2020 Dec 3. Clin Exp Rheumatol. 2020. PMID: 33275095 Free article.
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis.
Cassone G, Dolci G, Besutti G, Braglia L, Pavone P, Corsini R, Sampaolesi F, Iotti V, Teopompi E, Massari M, Fontana M, Ghidoni G, Matei A, Croci S, Negri EA, Costantini M, Facciolongo N, Salvarani C. Cassone G, et al. Among authors: teopompi e. PLoS One. 2022 Jan 26;17(1):e0262908. doi: 10.1371/journal.pone.0262908. eCollection 2022. PLoS One. 2022. PMID: 35081151 Free PMC article.
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D'Amico F, D'Elia E, Falco G, Gasparini S, Guerra S, Harari S, Kraft M, Mennella L, Papi A, Parrella R, Pelosi P, Poletti V, Polverino M, Tana C, Terribile R, Woods JC, Di Marco F, Martinez FD; ItaliCO study group. Polverino F, et al. Front Cardiovasc Med. 2020 Oct 9;7:585866. doi: 10.3389/fcvm.2020.585866. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33195473 Free PMC article.
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turrà C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Salvarani C, et al. Among authors: teopompi e. JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615. JAMA Intern Med. 2021. PMID: 33080005 Free PMC article. Clinical Trial.
17 results